Disgruntled Nobel loser sues; brain trauma researchers search for biomarker of a chronic condition; receptor for novel coronavirus found; the rise of transcriptomics; and ethical oversight of participant-led research
A surgeon sues the Nobel Assembly for excluding him from last year’s prize awarded for regenerative science, but stem cell scientists are skeptical of his claims.
The first researcher to clone the gene for green fluorescent protein, but who was passed over for the 2008 Nobel Prize in Chemistry, is back in academic science.
With dogged persistence and an unwillingness to entertain defeat, Bruce Beutler discovered a receptor that powers the innate immune response to infections—and earned his share of a Nobel Prize.
Amid Nobel Prize announcements this week, critics find awarding individuals in specific disciplines at odds with today’s interdisciplinary, team-led research.
Robert J. Lefkowitz and Brian K. Kobilka take home this year’s Nobel Prize for Chemistry for revealing how membrane receptors sense and respond to chemical signals.
Daniel Kahneman, who won a Nobel Prize in 2002, has issued a warning to a subset of his psychologist colleagues, telling them to increase the reproducibility of their research.